<?xml version="1.0" encoding="UTF-8"?>
<Label drug="adagen" track="TAC2017_ADR">
  <Text>
    <Section name="adverse reactions" id="S1">    ADVERSE REACTIONS

  Clinical experience with  ADAGEN  (r)    (pegademase bovine) Injection has been limited. The following adverse reactions were reported: headache in one patient and pain at the injection site in two patients. The following adverse reactions have been identified during post-approval use of  ADAGEN    (r)  (pegademase bovine) Injection. Because these reactions are reported voluntarily from a very small population, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure.



 Hematologic events: hemolytic anemia, auto-immune hemolytic anemia, thrombocythemia, thrombocytopenia and autoimmune thrombocytopenia.



 Dermatological events: injection site erythema, urticaria.Lymphomas



 To report SUSPECTED ADVERSE REACTIONS, contact Sigma-Tau Pharmaceuticals, Inc. at 1-888-393-4584 or by email at  drugsafety@sigmatau.com  or contact the FDA at 1-800-FDA-1088 or  www.fda.gov/safety/medwatch  .
</Section>
  </Text>
  <Mentions />
  <Relations />
  <Reactions />
</Label>
